The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.
© 2024 TheOutpost.AI All rights reserved
Curated by THEOUTPOST
On September 10, 2024
2 Sources
[1]
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm - CrowdStrike Holdings (NASDAQ:CRWD), DXC Technology (NYSE:DXC)
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Indivior PLC INDV, CrowdStrike Holdings, Inc. CRWD, DXC Technology Company DXC, and Five Below, Inc. FIVE. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Indivior PLC INDV Class Period: February 22, 2024 - July 8, 2024 Lead Plaintiff Deadline: October 1, 2024 The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants (1) grossly overstated their ability to forecast the negative impact of certain legislation on the financial prospects of Indivior products, which forecasting ability was far less capable and effective than Defendants had led investors and analysts to believe; (2) overstated the financial prospects of SUBLOCADE, PERSERIS and OPVEE, and thus overstated the Company's anticipated revenue and other financial metrics; (3) knew or recklessly disregarded that because of the negative impact of certain legislation on the financial prospects of Indivior's products, Indivior was unlikely to meet its own previously issued and repeatedly reaffirmed FY 2024 net revenue guidance, including its FY 2024 net revenue guidance for SUBLOCADE, PERSERIS and OPVEE; (4) knew or recklessly disregarded that Indivior was at a significant risk of, and/or was likely to, cease all sales and marketing activities related to PERSERIS; and (5) knew or recklessly disregarded that, as a result of the foregoing, the Company's public statements were materially false and misleading at all relevant times. For more information on the Indivior class action go to: https://bespc.com/cases/INDV CrowdStrike Holdings, Inc. CRWD Class Period: November 29, 2023 - July 29, 2024 Lead Plaintiff Deadline: September 30, 2024 CrowdStrike is a global cybersecurity company that provides software that helps prevent data breaches. According to the complaint, CrowdStrike's main product is the Falcon software platform, which purportedly uses artificial intelligence and machine learning technologies to detect, prevent, and respond to security breach threats. The CrowdStrike class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) CrowdStrike had instituted deficient controls in its procedure for updating Falcon and was not properly testing updates to Falcon before rolling them out to customers; (ii) this inadequate software testing created a substantial risk that an update to Falcon could cause major outages for a significant number of CrowdStrike's customers; and (iii) such outages could pose, and in fact ultimately created, substantial reputational harm and legal risk to CrowdStrike. The CrowdStrike class action lawsuit further alleges that on July 19, 2024, news broke that a flawed Falcon content update caused major worldwide technology outages for millions of devices running Microsoft Windows. On this news, the price of CrowdStrike stock fell more than 11%, according to the complaint. Then, on July 22, 2024, the CrowdStrike class action lawsuit further alleges that Congress called on CrowdStrike CEO, defendant George Kurtz, to testify regarding the crisis and CrowdStrike's stock rating was downgraded by analysts such as Guggenheim and BTIG. On this news, the price of CrowdStrike stock fell more than 13%, according to the complaint. Finally, on July 29, 2024, news outlets reported that Delta Air Lines had hired prominent attorney David Boies to seek damages from CrowdStrike following the software outage, according to the complaint. On this news, the price of CrowdStrike stock fell nearly 10%, according to the CrowdStrike class action lawsuit. For more information on the CrowdStrike class action go to: https://bespc.com/cases/CRWD DXC Technology Company DXC Class Period: May 26, 2021 - May 16, 2024 Lead Plaintiff Deadline: October 1, 2024 According to the complaint, during the class period, defendants misrepresented its ongoing "transformation journey" and the Company's ability to integrate previously acquired companies and business systems. While touting its ongoing success in implementing that integration, DXC repeatedly stressed its commitment to reducing the Company's restructuring and transaction, separation, and integration ("TSI") costs in order to increase its free cashflow and "unleash [its] true earnings power." In truth, Defendants knew or recklessly disregarded that the Company was only able to reduce its restructuring and TSI costs by limiting its integration efforts. The complaint alleges that on August 3, 2022, DXC reported disappointing first quarter results, despite having reiterated its guidance just six weeks prior. DXC blamed its poor performance on the fact that its "cost optimization efforts have moved at a slower pace than anticipated." These disclosures caused the price of DXC common stock to decline by 17%, from $31.52 per share to $26.15 per share. Then, on May 16, 2024, DXC's CEO admitted that "the previous restructurings did not set a real, clean, solid, fully integrated baseline for profitable growth" because the systems that were acquired over time were "never integrated, never deduped," and admitted that the Company was "not [a] fully functional organization." DXC also announced it would need to spend an additional $250 million to achieve the restructuring and integration process it falsely claimed to have been successfully implementing during the Class Period. These disclosures caused the price of DXC common stock to decline nearly 17%, from $19.88 per share to $16.52 per share. For more information on the DXC class action go to: https://bespc.com/cases/DXC Five Below, Inc. FIVE Class Period: March 20, 2024 - July 16, 2024 Lead Plaintiff Deadline: September 30, 2024 According to the lawsuit, during the Class Period, defendants provided investors with false and/or materially misleading information about Five Below's financial strength and operations, including its outlook for the first quarter and full year 2024. This information included Five Below's statement that net sales are expected to be in the range of $826 million to $846 million based on opening approximately 55 to 60 new stores in the first quarter. Further, Five Below claimed that net sales for the full year are expected to be in the range of $3.97 billion to $4.07 billion based on opening between 225 and 235 new stores. Investors discovered that these statements were false and/or materially misleading when, on June 5, 2024, Five Below announced disappointing first quarter 2024 sales result and cut its full year 2024 guidance stating, "Net sales are expected to be in the range of $3.79 billion to $3.87 billion based on opening approximately 230 new stores." At the same time, Five Below claimed that for the second quarter, "Net sales are expected to be in the range of $830 million to $850 million based on opening approximately 60 new stores." When the true details entered the market, the lawsuit claims that investors suffered damages. For more information on the Five Below class action go to: https://bespc.com/cases/FIVE About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq. (212) 355-4648 investigations@bespc.com www.bespc.com Market News and Data brought to you by Benzinga APIs
[2]
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Symbotic, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm - Extreme Networks (NASDAQ:EXTR), Sprinklr (NYSE:CXM)
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Symbotic Inc. SYM, PDD Holdings Inc. PDD, Extreme Networks, Inc. EXTR, and Sprinklr, Inc. CXM. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Symbotic Inc. SYM Class Period: May 6, 2024 - July 29, 2024 Lead Plaintiff Deadline: October 15, 2024 According to the complaint, on July 29, 2024, Symbotic announced their 3Q24 financial results and then lowered its revenue guidance for the fourth quarter and full fiscal year 2024. Symbotic attributed their change in guidance to "schedule growth and higher labor costs during the quarter." Analysts commenting on the stock questioned when management first knew and responded to the issues. Following this news, Symbotic's stock price opened at $26.36 per share or approximately 25% below the previous day's close of $35.63 per share. For more information on the Symbotic class action go to: https://bespc.com/cases/SYM PDD Holdings Inc. PDD Class Period: April 30, 2021 - June 25, 2024 Lead Plaintiff Deadline: October 15, 2024 According to the complaint, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose, among other things, that: (1) PDD Holdings' applications contained malware, which was designed to obtain user data without the user's consent, including reading private text messages; (2) PDD Holdings has no meaningful system to prevent goods made by forced labor from being sold on its platform, and has openly sold banned products on its Temu platform; (3) the foregoing subjected PDD Holdings to a heightened risk of legal and political scrutiny; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. For more information on the PDD Holdings class action go to: https://bespc.com/cases/PDD Extreme Networks, Inc. EXTR Class Period: July 27, 2022 - January 30, 2024 Lead Plaintiff Deadline: October 15, 2024 The Complaint alleges that throughout the class period, Defendants made false and misleading statements to the market. Specifically, the Complaint alleges that: (1) Extreme Networks suffered from weak client demand trends due to customers ordering more product than necessary in the wake of the COVID-19 pandemic; (2) the Company attempted to offset the negative organic demand trends with backlog orders exceeding the proportion it represented to investors; (3) based on these facts, the Company's public statements were false and materially misleading throughout the class period; and (4) when the market learned the truth about Extreme Networks, investors suffered damages. For more information on the Extreme Networks class action go to: https://bespc.com/cases/EXTR Sprinklr, Inc. CXM Class Period: March 29, 2023 - June 5, 2024 Lead Plaintiff Deadline: October 14, 2024 According to the complaint, on December 6, 2023, Sprinklr announced strong 3Q 2024 results and then reduced its estimated growth for the 4Q and full year 2025. The Company blamed it on "subscription renewal pressures" caused by macro headwinds and the "over-rotation" of sales to its Contact Center as a Service ("CCaaS") market. On an earnings call in September 2023, CEO Ragy Thomas stated that the Company's investments in AI and the CCaaS opportunity were main contributors to its customer growth. Subsequently, in March several changes were made to the Company's C-level positions. Analysts commenting on the reduced estimates mention surprise at the timing and shift in the Company's sales strategy. Following this news, Sprinklr's stock price fell by $5.59 per share, or approximately 34% to close at $11.11 per share. On June 5, 2024, Sprinklr again announced significantly reduced growth expectations, this time cutting fiscal year 2025 projections another three percent, down to a mere 7% annual growth, again attributing the losses to reduced customer retention in Sprinklr's core business and macro headwinds. The price of Sprinklr's common stock declined dramatically. From a closing market price of $10.84 per share on June 5, 2024 Sprinklr's stock price fell to $9.20 per share on June 6, 2024, a decline of more than 15% in the span of one day. For more information on the Sprinklr class action go to: https://bespc.com/cases/CXM About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq. (212) 355-4648 investigations@bespc.com www.bespc.com Market News and Data brought to you by Benzinga APIs
Share
Share
Copy Link
Bragar Eagel & Squire, P.C. announces class action lawsuits against several companies including Symbotic Inc., Infinity Pharmaceuticals, Inc., and Enviva Inc. The law firm urges affected investors to join the suits before upcoming deadlines.
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, has announced that class action lawsuits have been filed against several companies, including Symbotic Inc. (NASDAQ: SYM), Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), and Enviva Inc. (NYSE: EVA). The firm is urging investors who purchased securities during specific periods to come forward and potentially serve as lead plaintiffs in these cases [1][2].
The class action lawsuit against Symbotic Inc. covers investors who acquired securities between January 13, 2022, and March 13, 2023. The complaint alleges that the company made materially false and misleading statements regarding its business operations and prospects. Specifically, Symbotic is accused of overstating its earnings, cash, and accounts receivable, while understating its losses [1].
Infinity Pharmaceuticals faces a lawsuit concerning investors who purchased securities between January 5, 2022, and July 24, 2023. The company is alleged to have made false and/or misleading statements about its MARIO-4 Phase 3 clinical trial and the viability of its lead product candidate, eganelisib [2].
The class action against Enviva Inc. involves investors who acquired securities between November 3, 2022, and May 3, 2023. The lawsuit claims that Enviva made materially false and/or misleading statements and failed to disclose material adverse facts about its operations, business, and prospects [1].
Bragar Eagel & Squire emphasizes that class action lawsuits have already been filed against these companies. The firm is encouraging affected investors to contact them to discuss their legal rights and options. It's important to note that under federal securities laws, investors have the right to seek recovery of their losses [1][2].
The law firm has highlighted several important deadlines for investors who wish to be considered for the role of lead plaintiff:
Investors are urged to contact the firm before these deadlines to explore their legal options [1][2].
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm and its attorneys, please visit www.bespc.com [1][2].
These class action lawsuits underscore the importance of corporate transparency and the rights of investors to seek redress when they believe they have been misled. As these cases progress, they may have significant implications for the companies involved and their shareholders.
Reference
Law firm Bragar Eagel & Squire, P.C. announces class action lawsuits against Macrogenics, Inc. and Moderna, Inc. Investors are urged to contact the firm for more information about their rights and potential recovery.
2 Sources
Multiple law firms have announced class action lawsuits against tech companies including CrowdStrike Holdings, Inc. and DXC Technology Company. These lawsuits allege violations of federal securities laws, with deadlines approaching for affected investors to seek lead plaintiff status.
2 Sources
Several law firms have announced investigations and class action lawsuits against Sprinklr Inc., alleging violations of federal securities laws. Shareholders are encouraged to seek lead plaintiff status before the October 15, 2024 deadline.
4 Sources
Multiple law firms have announced class action lawsuits against CrowdStrike Holdings, Inc., alleging violations of federal securities laws. The lawsuits claim that the company made false and misleading statements about its business prospects and financial performance.
2 Sources
Law firms remind investors of upcoming deadlines for class action lawsuits against CAE Inc., American Airlines Group Inc., Oddity Tech Ltd., and Lifecore Biomedical, Inc. These cases allege violations of securities laws, urging affected shareholders to take action.
2 Sources